-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Hematology Inclusion Pathway (HIP) Oral Presentations - Health Services Outcomes

Program: Special-Interest Sessions
Hematology Disease Topics & Pathways:
Diversity, Equity, and Inclusion (DEI)
Saturday, December 7, 2024: 6:00 PM-9:00 PM
Marina Ballroom F (Marriott Marquis San Diego Marina)
Moderators:
Joanna Robles, MD, Atrium Health Wake Forest Baptist Brenner Children’s Hospital and Oreofe O. Odejide, MD, MPH, Dana-Farber Cancer Institute and Staci D. Arnold, MD, MBA, MPH, Aflac Canver and Blood Disorders Center at Children's Healthcare of Atlanta, Emory University
Disclosures:
No relevant conflicts of interest to declare.
The Hematology Inclusion Pathway Presentations and Reception (previously known as Promoting Minorities in Hematology); ASH invites all interested meeting attendees to this event, which will showcase the research of our Hematology Inclusion Pathway awardees. This initiative is a comprehensive 13-year longitudinal career pathway of awards that strives to ensure that hematology reflects and serves the diverse world we live in. The highlight of the session will be oral scientific presentations from program participants. 
Exploring Mental Health in Sickle Cell Disease: Implementing Routine Psychological Assessment in a Comprehensive Sickle Cell Clinic

Emily Franco, BA

The Warren Alpert Medical School of Brown University, Davie, FL
Outcomes of Adult ALL/LBL Patients from Diverse Backgrounds Treated in the United States between 2000 and 2022

Rachelle Monteau

CUNY School of Medicine, New York, NY
Neighborhood Socioeconomic/Environmental Disadvantage and Health Outcomes after Allogeneic Hematopoietic Cell Transplantation

Osariemen Ogiamien

University of California Riverside Science Library, Riverside, CA
Parenthood While in Hematology: Perceived Barriers

Margarita Vazquez Almonte

SUNY Upstate Medical University, Bronx, NY
Outcomes of Patients Underrepresented in Pivotal Trials of CAR-T Cell Therapy

Daniel Goyco Vera, MD

Baylor College of Medicine, Houston, TX
The Impact of Structural Racism on Molecular Subtypes and Survival Outcomes in Acute Myeloid Leukemia Patients

Michelle Nwachukwu, DO

University of Illinois at Chicago, Chicago, IL
Examining the Impact of Body Mass Index on Outcomes in Young Adults with Sickle Cell Disease: A Single-Center Study

Ifeanyi Nnamdi Uche, MBBS

Department of Medicine, One Brookdale University Hospital and Medical Center, Brooklyn, NY
Integration of Health Literacy Universal Precautions into Clinical Practice as a Strategy to Improve Patient-Reported Outcomes in Patients with Hematologic Malignancies and Limited English Proficiency

Britney Bell, MD

Section of Hematology and Medical Oncology, Boston Medical Center, Boston, MA
Impact of Daratumumab in the Treatment of Vulnerable Transplant Eligible Multiple Myeloma Patients and Its Utilization in Blacks

Eden Ayele Biltibo, MD, MS

Vanderbilt University Medical Center, Nashville, TN
A Step Toward Individualized Mortality Risk Prediction in Patients with Sickle Cell Disease in a National EHR-Derived Population Dataset

Gerard Hills, MD

Riley Hospital for Children at Indiana University Health, Indianapolis, IN
Alternative Dosing and Prevention of Transfusions (ADAPT): A Prospective Trial to Quantify the Change in Blood Transfusion Use with Hydroxyurea Treatment and the Feasibility of Pharmacokinetic-Guided Dosing in Children with Sickle Cell Anemia in Uganda

Alexandra Power-Hays, MD

Division of Hematology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
See more of: Special-Interest Sessions
<< Previous Session | Next Session >>